Dr. Djurhuus commented, “I am excited to join Clinical ink at a time when the convergence of digital health, clinical science, and patient‑centric data capture is creating new opportunities. I look forward to helping advance a disease management solution that delivers meaningful impact for patients while strengthening evidence generation for biopharma partners.”
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.